AG

Aayushman Gupta

Active Director Director DIN 09715755
DIN 09715755 First appointment Aug 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Aayushman Gupta

Data last updated:

Aayushman Gupta is a Director at Prasuk Research Institute For Medical Education Private Limited (since 2022). The company operates in Healthcare.

DIN 09715755
Primary Designation Director
Industry Healthcare
First Appointment 25 Aug 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Aug 20222022Active

Board colleagues of Aayushman Gupta

Directorship timeline

Open interactive timeline →
Prasuk Research Institute For Medical Education Private Limited
Premium access

Shareholding and investment profile for Aayushman Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aayushman Gupta

Aayushman Gupta currently holds 1 directorship: Prasuk Research Institute For Medical Education Private Limited (Director, since 25 Aug 2022).

Aayushman Gupta was first appointed on 25 Aug 2022 as Director at Prasuk Research Institute For Medical Education Private Limited.

The current boards of Aayushman Gupta's companies include Pramod Kumar Khare (Prasuk Research Institute For Medical Education Private Limited), Ragini Gangwal (Prasuk Research Institute For Medical Education Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available